Global Immune Drugs Supply, Demand and Key Producers, 2023-2029
The global Immune Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Immune Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Immune Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immune Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Immune Drugs total production and demand, 2018-2029, (K Units)
Global Immune Drugs total production value, 2018-2029, (USD Million)
Global Immune Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Immune Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Immune Drugs domestic production, consumption, key domestic manufacturers and share
Global Immune Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Immune Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Immune Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Immune Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Antares Pharma, Inc., UCB, Incyte, GSK, Takeda, 3S Bio, Horizo??n Therapeutics, Bristol-Myers Squibb (BMS and Astellas, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Immune Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Immune Drugs Market, By Region:
1. How big is the global Immune Drugs market?
2. What is the demand of the global Immune Drugs market?
3. What is the year over year growth of the global Immune Drugs market?
4. What is the production and production value of the global Immune Drugs market?
5. Who are the key producers in the global Immune Drugs market?
6. What are the growth factors driving the market demand?
This report studies the global Immune Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Immune Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immune Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Immune Drugs total production and demand, 2018-2029, (K Units)
Global Immune Drugs total production value, 2018-2029, (USD Million)
Global Immune Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Immune Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Immune Drugs domestic production, consumption, key domestic manufacturers and share
Global Immune Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Immune Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Immune Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Immune Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Antares Pharma, Inc., UCB, Incyte, GSK, Takeda, 3S Bio, Horizo??n Therapeutics, Bristol-Myers Squibb (BMS and Astellas, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Immune Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Immune Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Immune Boosting Drugs
- Immunosuppressant Drugs
- Hospital
- Clinic
- Surgery Center
- Others
- Antares Pharma, Inc.
- UCB
- Incyte
- GSK
- Takeda
- 3S Bio
- Horizo??n Therapeutics
- Bristol-Myers Squibb (BMS
- Astellas
- Eli Lilly
- Mitsubishi Tanabe Pharma
- Biogen
- Pfizer
- Sanofi
- Roche
- Novartis
- Johnson & Johnson (J&J)
- Amgen
- Abbvi
1. How big is the global Immune Drugs market?
2. What is the demand of the global Immune Drugs market?
3. What is the year over year growth of the global Immune Drugs market?
4. What is the production and production value of the global Immune Drugs market?
5. Who are the key producers in the global Immune Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Immune Drugs Introduction
1.2 World Immune Drugs Supply & Forecast
1.2.1 World Immune Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Immune Drugs Production (2018-2029)
1.2.3 World Immune Drugs Pricing Trends (2018-2029)
1.3 World Immune Drugs Production by Region (Based on Production Site)
1.3.1 World Immune Drugs Production Value by Region (2018-2029)
1.3.2 World Immune Drugs Production by Region (2018-2029)
1.3.3 World Immune Drugs Average Price by Region (2018-2029)
1.3.4 North America Immune Drugs Production (2018-2029)
1.3.5 Europe Immune Drugs Production (2018-2029)
1.3.6 China Immune Drugs Production (2018-2029)
1.3.7 Japan Immune Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Immune Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Immune Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Immune Drugs Demand (2018-2029)
2.2 World Immune Drugs Consumption by Region
2.2.1 World Immune Drugs Consumption by Region (2018-2023)
2.2.2 World Immune Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Immune Drugs Consumption (2018-2029)
2.4 China Immune Drugs Consumption (2018-2029)
2.5 Europe Immune Drugs Consumption (2018-2029)
2.6 Japan Immune Drugs Consumption (2018-2029)
2.7 South Korea Immune Drugs Consumption (2018-2029)
2.8 ASEAN Immune Drugs Consumption (2018-2029)
2.9 India Immune Drugs Consumption (2018-2029)
3 WORLD IMMUNE DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Immune Drugs Production Value by Manufacturer (2018-2023)
3.2 World Immune Drugs Production by Manufacturer (2018-2023)
3.3 World Immune Drugs Average Price by Manufacturer (2018-2023)
3.4 Immune Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Immune Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Immune Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Immune Drugs in 2022
3.6 Immune Drugs Market: Overall Company Footprint Analysis
3.6.1 Immune Drugs Market: Region Footprint
3.6.2 Immune Drugs Market: Company Product Type Footprint
3.6.3 Immune Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Immune Drugs Production Value Comparison
4.1.1 United States VS China: Immune Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Immune Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Immune Drugs Production Comparison
4.2.1 United States VS China: Immune Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Immune Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Immune Drugs Consumption Comparison
4.3.1 United States VS China: Immune Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Immune Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Immune Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Immune Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Immune Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Immune Drugs Production (2018-2023)
4.5 China Based Immune Drugs Manufacturers and Market Share
4.5.1 China Based Immune Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Immune Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Immune Drugs Production (2018-2023)
4.6 Rest of World Based Immune Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Immune Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Immune Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Immune Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Immune Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Immune Boosting Drugs
5.2.2 Immunosuppressant Drugs
5.3 Market Segment by Type
5.3.1 World Immune Drugs Production by Type (2018-2029)
5.3.2 World Immune Drugs Production Value by Type (2018-2029)
5.3.3 World Immune Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Immune Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Surgery Center
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Immune Drugs Production by Application (2018-2029)
6.3.2 World Immune Drugs Production Value by Application (2018-2029)
6.3.3 World Immune Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Antares Pharma, Inc.
7.1.1 Antares Pharma, Inc. Details
7.1.2 Antares Pharma, Inc. Major Business
7.1.3 Antares Pharma, Inc. Immune Drugs Product and Services
7.1.4 Antares Pharma, Inc. Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Antares Pharma, Inc. Recent Developments/Updates
7.1.6 Antares Pharma, Inc. Competitive Strengths & Weaknesses
7.2 UCB
7.2.1 UCB Details
7.2.2 UCB Major Business
7.2.3 UCB Immune Drugs Product and Services
7.2.4 UCB Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 UCB Recent Developments/Updates
7.2.6 UCB Competitive Strengths & Weaknesses
7.3 Incyte
7.3.1 Incyte Details
7.3.2 Incyte Major Business
7.3.3 Incyte Immune Drugs Product and Services
7.3.4 Incyte Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Incyte Recent Developments/Updates
7.3.6 Incyte Competitive Strengths & Weaknesses
7.4 GSK
7.4.1 GSK Details
7.4.2 GSK Major Business
7.4.3 GSK Immune Drugs Product and Services
7.4.4 GSK Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 GSK Recent Developments/Updates
7.4.6 GSK Competitive Strengths & Weaknesses
7.5 Takeda
7.5.1 Takeda Details
7.5.2 Takeda Major Business
7.5.3 Takeda Immune Drugs Product and Services
7.5.4 Takeda Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Takeda Recent Developments/Updates
7.5.6 Takeda Competitive Strengths & Weaknesses
7.6 3S Bio
7.6.1 3S Bio Details
7.6.2 3S Bio Major Business
7.6.3 3S Bio Immune Drugs Product and Services
7.6.4 3S Bio Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 3S Bio Recent Developments/Updates
7.6.6 3S Bio Competitive Strengths & Weaknesses
7.7 Horizo??n Therapeutics
7.7.1 Horizo??n Therapeutics Details
7.7.2 Horizo??n Therapeutics Major Business
7.7.3 Horizo??n Therapeutics Immune Drugs Product and Services
7.7.4 Horizo??n Therapeutics Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Horizo??n Therapeutics Recent Developments/Updates
7.7.6 Horizo??n Therapeutics Competitive Strengths & Weaknesses
7.8 Bristol-Myers Squibb (BMS
7.8.1 Bristol-Myers Squibb (BMS Details
7.8.2 Bristol-Myers Squibb (BMS Major Business
7.8.3 Bristol-Myers Squibb (BMS Immune Drugs Product and Services
7.8.4 Bristol-Myers Squibb (BMS Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Bristol-Myers Squibb (BMS Recent Developments/Updates
7.8.6 Bristol-Myers Squibb (BMS Competitive Strengths & Weaknesses
7.9 Astellas
7.9.1 Astellas Details
7.9.2 Astellas Major Business
7.9.3 Astellas Immune Drugs Product and Services
7.9.4 Astellas Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Astellas Recent Developments/Updates
7.9.6 Astellas Competitive Strengths & Weaknesses
7.10 Eli Lilly
7.10.1 Eli Lilly Details
7.10.2 Eli Lilly Major Business
7.10.3 Eli Lilly Immune Drugs Product and Services
7.10.4 Eli Lilly Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Eli Lilly Recent Developments/Updates
7.10.6 Eli Lilly Competitive Strengths & Weaknesses
7.11 Mitsubishi Tanabe Pharma
7.11.1 Mitsubishi Tanabe Pharma Details
7.11.2 Mitsubishi Tanabe Pharma Major Business
7.11.3 Mitsubishi Tanabe Pharma Immune Drugs Product and Services
7.11.4 Mitsubishi Tanabe Pharma Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
7.11.6 Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
7.12 Biogen
7.12.1 Biogen Details
7.12.2 Biogen Major Business
7.12.3 Biogen Immune Drugs Product and Services
7.12.4 Biogen Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Biogen Recent Developments/Updates
7.12.6 Biogen Competitive Strengths & Weaknesses
7.13 Pfizer
7.13.1 Pfizer Details
7.13.2 Pfizer Major Business
7.13.3 Pfizer Immune Drugs Product and Services
7.13.4 Pfizer Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Pfizer Recent Developments/Updates
7.13.6 Pfizer Competitive Strengths & Weaknesses
7.14 Sanofi
7.14.1 Sanofi Details
7.14.2 Sanofi Major Business
7.14.3 Sanofi Immune Drugs Product and Services
7.14.4 Sanofi Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Sanofi Recent Developments/Updates
7.14.6 Sanofi Competitive Strengths & Weaknesses
7.15 Roche
7.15.1 Roche Details
7.15.2 Roche Major Business
7.15.3 Roche Immune Drugs Product and Services
7.15.4 Roche Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Roche Recent Developments/Updates
7.15.6 Roche Competitive Strengths & Weaknesses
7.16 Novartis
7.16.1 Novartis Details
7.16.2 Novartis Major Business
7.16.3 Novartis Immune Drugs Product and Services
7.16.4 Novartis Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Novartis Recent Developments/Updates
7.16.6 Novartis Competitive Strengths & Weaknesses
7.17 Johnson & Johnson (J&J)
7.17.1 Johnson & Johnson (J&J) Details
7.17.2 Johnson & Johnson (J&J) Major Business
7.17.3 Johnson & Johnson (J&J) Immune Drugs Product and Services
7.17.4 Johnson & Johnson (J&J) Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Johnson & Johnson (J&J) Recent Developments/Updates
7.17.6 Johnson & Johnson (J&J) Competitive Strengths & Weaknesses
7.18 Amgen
7.18.1 Amgen Details
7.18.2 Amgen Major Business
7.18.3 Amgen Immune Drugs Product and Services
7.18.4 Amgen Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Amgen Recent Developments/Updates
7.18.6 Amgen Competitive Strengths & Weaknesses
7.19 Abbvi
7.19.1 Abbvi Details
7.19.2 Abbvi Major Business
7.19.3 Abbvi Immune Drugs Product and Services
7.19.4 Abbvi Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Abbvi Recent Developments/Updates
7.19.6 Abbvi Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Immune Drugs Industry Chain
8.2 Immune Drugs Upstream Analysis
8.2.1 Immune Drugs Core Raw Materials
8.2.2 Main Manufacturers of Immune Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Immune Drugs Production Mode
8.6 Immune Drugs Procurement Model
8.7 Immune Drugs Industry Sales Model and Sales Channels
8.7.1 Immune Drugs Sales Model
8.7.2 Immune Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Immune Drugs Introduction
1.2 World Immune Drugs Supply & Forecast
1.2.1 World Immune Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Immune Drugs Production (2018-2029)
1.2.3 World Immune Drugs Pricing Trends (2018-2029)
1.3 World Immune Drugs Production by Region (Based on Production Site)
1.3.1 World Immune Drugs Production Value by Region (2018-2029)
1.3.2 World Immune Drugs Production by Region (2018-2029)
1.3.3 World Immune Drugs Average Price by Region (2018-2029)
1.3.4 North America Immune Drugs Production (2018-2029)
1.3.5 Europe Immune Drugs Production (2018-2029)
1.3.6 China Immune Drugs Production (2018-2029)
1.3.7 Japan Immune Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Immune Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Immune Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Immune Drugs Demand (2018-2029)
2.2 World Immune Drugs Consumption by Region
2.2.1 World Immune Drugs Consumption by Region (2018-2023)
2.2.2 World Immune Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Immune Drugs Consumption (2018-2029)
2.4 China Immune Drugs Consumption (2018-2029)
2.5 Europe Immune Drugs Consumption (2018-2029)
2.6 Japan Immune Drugs Consumption (2018-2029)
2.7 South Korea Immune Drugs Consumption (2018-2029)
2.8 ASEAN Immune Drugs Consumption (2018-2029)
2.9 India Immune Drugs Consumption (2018-2029)
3 WORLD IMMUNE DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Immune Drugs Production Value by Manufacturer (2018-2023)
3.2 World Immune Drugs Production by Manufacturer (2018-2023)
3.3 World Immune Drugs Average Price by Manufacturer (2018-2023)
3.4 Immune Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Immune Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Immune Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Immune Drugs in 2022
3.6 Immune Drugs Market: Overall Company Footprint Analysis
3.6.1 Immune Drugs Market: Region Footprint
3.6.2 Immune Drugs Market: Company Product Type Footprint
3.6.3 Immune Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Immune Drugs Production Value Comparison
4.1.1 United States VS China: Immune Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Immune Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Immune Drugs Production Comparison
4.2.1 United States VS China: Immune Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Immune Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Immune Drugs Consumption Comparison
4.3.1 United States VS China: Immune Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Immune Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Immune Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Immune Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Immune Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Immune Drugs Production (2018-2023)
4.5 China Based Immune Drugs Manufacturers and Market Share
4.5.1 China Based Immune Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Immune Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Immune Drugs Production (2018-2023)
4.6 Rest of World Based Immune Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Immune Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Immune Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Immune Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Immune Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Immune Boosting Drugs
5.2.2 Immunosuppressant Drugs
5.3 Market Segment by Type
5.3.1 World Immune Drugs Production by Type (2018-2029)
5.3.2 World Immune Drugs Production Value by Type (2018-2029)
5.3.3 World Immune Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Immune Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Surgery Center
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Immune Drugs Production by Application (2018-2029)
6.3.2 World Immune Drugs Production Value by Application (2018-2029)
6.3.3 World Immune Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Antares Pharma, Inc.
7.1.1 Antares Pharma, Inc. Details
7.1.2 Antares Pharma, Inc. Major Business
7.1.3 Antares Pharma, Inc. Immune Drugs Product and Services
7.1.4 Antares Pharma, Inc. Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Antares Pharma, Inc. Recent Developments/Updates
7.1.6 Antares Pharma, Inc. Competitive Strengths & Weaknesses
7.2 UCB
7.2.1 UCB Details
7.2.2 UCB Major Business
7.2.3 UCB Immune Drugs Product and Services
7.2.4 UCB Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 UCB Recent Developments/Updates
7.2.6 UCB Competitive Strengths & Weaknesses
7.3 Incyte
7.3.1 Incyte Details
7.3.2 Incyte Major Business
7.3.3 Incyte Immune Drugs Product and Services
7.3.4 Incyte Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Incyte Recent Developments/Updates
7.3.6 Incyte Competitive Strengths & Weaknesses
7.4 GSK
7.4.1 GSK Details
7.4.2 GSK Major Business
7.4.3 GSK Immune Drugs Product and Services
7.4.4 GSK Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 GSK Recent Developments/Updates
7.4.6 GSK Competitive Strengths & Weaknesses
7.5 Takeda
7.5.1 Takeda Details
7.5.2 Takeda Major Business
7.5.3 Takeda Immune Drugs Product and Services
7.5.4 Takeda Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Takeda Recent Developments/Updates
7.5.6 Takeda Competitive Strengths & Weaknesses
7.6 3S Bio
7.6.1 3S Bio Details
7.6.2 3S Bio Major Business
7.6.3 3S Bio Immune Drugs Product and Services
7.6.4 3S Bio Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 3S Bio Recent Developments/Updates
7.6.6 3S Bio Competitive Strengths & Weaknesses
7.7 Horizo??n Therapeutics
7.7.1 Horizo??n Therapeutics Details
7.7.2 Horizo??n Therapeutics Major Business
7.7.3 Horizo??n Therapeutics Immune Drugs Product and Services
7.7.4 Horizo??n Therapeutics Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Horizo??n Therapeutics Recent Developments/Updates
7.7.6 Horizo??n Therapeutics Competitive Strengths & Weaknesses
7.8 Bristol-Myers Squibb (BMS
7.8.1 Bristol-Myers Squibb (BMS Details
7.8.2 Bristol-Myers Squibb (BMS Major Business
7.8.3 Bristol-Myers Squibb (BMS Immune Drugs Product and Services
7.8.4 Bristol-Myers Squibb (BMS Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Bristol-Myers Squibb (BMS Recent Developments/Updates
7.8.6 Bristol-Myers Squibb (BMS Competitive Strengths & Weaknesses
7.9 Astellas
7.9.1 Astellas Details
7.9.2 Astellas Major Business
7.9.3 Astellas Immune Drugs Product and Services
7.9.4 Astellas Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Astellas Recent Developments/Updates
7.9.6 Astellas Competitive Strengths & Weaknesses
7.10 Eli Lilly
7.10.1 Eli Lilly Details
7.10.2 Eli Lilly Major Business
7.10.3 Eli Lilly Immune Drugs Product and Services
7.10.4 Eli Lilly Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Eli Lilly Recent Developments/Updates
7.10.6 Eli Lilly Competitive Strengths & Weaknesses
7.11 Mitsubishi Tanabe Pharma
7.11.1 Mitsubishi Tanabe Pharma Details
7.11.2 Mitsubishi Tanabe Pharma Major Business
7.11.3 Mitsubishi Tanabe Pharma Immune Drugs Product and Services
7.11.4 Mitsubishi Tanabe Pharma Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
7.11.6 Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
7.12 Biogen
7.12.1 Biogen Details
7.12.2 Biogen Major Business
7.12.3 Biogen Immune Drugs Product and Services
7.12.4 Biogen Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Biogen Recent Developments/Updates
7.12.6 Biogen Competitive Strengths & Weaknesses
7.13 Pfizer
7.13.1 Pfizer Details
7.13.2 Pfizer Major Business
7.13.3 Pfizer Immune Drugs Product and Services
7.13.4 Pfizer Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Pfizer Recent Developments/Updates
7.13.6 Pfizer Competitive Strengths & Weaknesses
7.14 Sanofi
7.14.1 Sanofi Details
7.14.2 Sanofi Major Business
7.14.3 Sanofi Immune Drugs Product and Services
7.14.4 Sanofi Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Sanofi Recent Developments/Updates
7.14.6 Sanofi Competitive Strengths & Weaknesses
7.15 Roche
7.15.1 Roche Details
7.15.2 Roche Major Business
7.15.3 Roche Immune Drugs Product and Services
7.15.4 Roche Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Roche Recent Developments/Updates
7.15.6 Roche Competitive Strengths & Weaknesses
7.16 Novartis
7.16.1 Novartis Details
7.16.2 Novartis Major Business
7.16.3 Novartis Immune Drugs Product and Services
7.16.4 Novartis Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Novartis Recent Developments/Updates
7.16.6 Novartis Competitive Strengths & Weaknesses
7.17 Johnson & Johnson (J&J)
7.17.1 Johnson & Johnson (J&J) Details
7.17.2 Johnson & Johnson (J&J) Major Business
7.17.3 Johnson & Johnson (J&J) Immune Drugs Product and Services
7.17.4 Johnson & Johnson (J&J) Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Johnson & Johnson (J&J) Recent Developments/Updates
7.17.6 Johnson & Johnson (J&J) Competitive Strengths & Weaknesses
7.18 Amgen
7.18.1 Amgen Details
7.18.2 Amgen Major Business
7.18.3 Amgen Immune Drugs Product and Services
7.18.4 Amgen Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Amgen Recent Developments/Updates
7.18.6 Amgen Competitive Strengths & Weaknesses
7.19 Abbvi
7.19.1 Abbvi Details
7.19.2 Abbvi Major Business
7.19.3 Abbvi Immune Drugs Product and Services
7.19.4 Abbvi Immune Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Abbvi Recent Developments/Updates
7.19.6 Abbvi Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Immune Drugs Industry Chain
8.2 Immune Drugs Upstream Analysis
8.2.1 Immune Drugs Core Raw Materials
8.2.2 Main Manufacturers of Immune Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Immune Drugs Production Mode
8.6 Immune Drugs Procurement Model
8.7 Immune Drugs Industry Sales Model and Sales Channels
8.7.1 Immune Drugs Sales Model
8.7.2 Immune Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Immune Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Immune Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Immune Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Immune Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Immune Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Immune Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Immune Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Immune Drugs Production Market Share by Region (2018-2023)
Table 9. World Immune Drugs Production Market Share by Region (2024-2029)
Table 10. World Immune Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Immune Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Immune Drugs Major Market Trends
Table 13. World Immune Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Immune Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Immune Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Immune Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Immune Drugs Producers in 2022
Table 18. World Immune Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Immune Drugs Producers in 2022
Table 20. World Immune Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Immune Drugs Company Evaluation Quadrant
Table 22. World Immune Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Immune Drugs Production Site of Key Manufacturer
Table 24. Immune Drugs Market: Company Product Type Footprint
Table 25. Immune Drugs Market: Company Product Application Footprint
Table 26. Immune Drugs Competitive Factors
Table 27. Immune Drugs New Entrant and Capacity Expansion Plans
Table 28. Immune Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Immune Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Immune Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Immune Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Immune Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Immune Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Immune Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Immune Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Immune Drugs Production Market Share (2018-2023)
Table 37. China Based Immune Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Immune Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Immune Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Immune Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Immune Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Immune Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Immune Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Immune Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Immune Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Immune Drugs Production Market Share (2018-2023)
Table 47. World Immune Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Immune Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Immune Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Immune Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Immune Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Immune Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Immune Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Immune Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Immune Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Immune Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Immune Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Immune Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Immune Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Immune Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Antares Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Antares Pharma, Inc. Major Business
Table 63. Antares Pharma, Inc. Immune Drugs Product and Services
Table 64. Antares Pharma, Inc. Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Antares Pharma, Inc. Recent Developments/Updates
Table 66. Antares Pharma, Inc. Competitive Strengths & Weaknesses
Table 67. UCB Basic Information, Manufacturing Base and Competitors
Table 68. UCB Major Business
Table 69. UCB Immune Drugs Product and Services
Table 70. UCB Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. UCB Recent Developments/Updates
Table 72. UCB Competitive Strengths & Weaknesses
Table 73. Incyte Basic Information, Manufacturing Base and Competitors
Table 74. Incyte Major Business
Table 75. Incyte Immune Drugs Product and Services
Table 76. Incyte Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Incyte Recent Developments/Updates
Table 78. Incyte Competitive Strengths & Weaknesses
Table 79. GSK Basic Information, Manufacturing Base and Competitors
Table 80. GSK Major Business
Table 81. GSK Immune Drugs Product and Services
Table 82. GSK Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. GSK Recent Developments/Updates
Table 84. GSK Competitive Strengths & Weaknesses
Table 85. Takeda Basic Information, Manufacturing Base and Competitors
Table 86. Takeda Major Business
Table 87. Takeda Immune Drugs Product and Services
Table 88. Takeda Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Takeda Recent Developments/Updates
Table 90. Takeda Competitive Strengths & Weaknesses
Table 91. 3S Bio Basic Information, Manufacturing Base and Competitors
Table 92. 3S Bio Major Business
Table 93. 3S Bio Immune Drugs Product and Services
Table 94. 3S Bio Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. 3S Bio Recent Developments/Updates
Table 96. 3S Bio Competitive Strengths & Weaknesses
Table 97. Horizo??n Therapeutics Basic Information, Manufacturing Base and Competitors
Table 98. Horizo??n Therapeutics Major Business
Table 99. Horizo??n Therapeutics Immune Drugs Product and Services
Table 100. Horizo??n Therapeutics Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Horizo??n Therapeutics Recent Developments/Updates
Table 102. Horizo??n Therapeutics Competitive Strengths & Weaknesses
Table 103. Bristol-Myers Squibb (BMS Basic Information, Manufacturing Base and Competitors
Table 104. Bristol-Myers Squibb (BMS Major Business
Table 105. Bristol-Myers Squibb (BMS Immune Drugs Product and Services
Table 106. Bristol-Myers Squibb (BMS Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Bristol-Myers Squibb (BMS Recent Developments/Updates
Table 108. Bristol-Myers Squibb (BMS Competitive Strengths & Weaknesses
Table 109. Astellas Basic Information, Manufacturing Base and Competitors
Table 110. Astellas Major Business
Table 111. Astellas Immune Drugs Product and Services
Table 112. Astellas Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Astellas Recent Developments/Updates
Table 114. Astellas Competitive Strengths & Weaknesses
Table 115. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 116. Eli Lilly Major Business
Table 117. Eli Lilly Immune Drugs Product and Services
Table 118. Eli Lilly Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Eli Lilly Recent Developments/Updates
Table 120. Eli Lilly Competitive Strengths & Weaknesses
Table 121. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 122. Mitsubishi Tanabe Pharma Major Business
Table 123. Mitsubishi Tanabe Pharma Immune Drugs Product and Services
Table 124. Mitsubishi Tanabe Pharma Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 126. Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
Table 127. Biogen Basic Information, Manufacturing Base and Competitors
Table 128. Biogen Major Business
Table 129. Biogen Immune Drugs Product and Services
Table 130. Biogen Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Biogen Recent Developments/Updates
Table 132. Biogen Competitive Strengths & Weaknesses
Table 133. Pfizer Basic Information, Manufacturing Base and Competitors
Table 134. Pfizer Major Business
Table 135. Pfizer Immune Drugs Product and Services
Table 136. Pfizer Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Pfizer Recent Developments/Updates
Table 138. Pfizer Competitive Strengths & Weaknesses
Table 139. Sanofi Basic Information, Manufacturing Base and Competitors
Table 140. Sanofi Major Business
Table 141. Sanofi Immune Drugs Product and Services
Table 142. Sanofi Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Sanofi Recent Developments/Updates
Table 144. Sanofi Competitive Strengths & Weaknesses
Table 145. Roche Basic Information, Manufacturing Base and Competitors
Table 146. Roche Major Business
Table 147. Roche Immune Drugs Product and Services
Table 148. Roche Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Roche Recent Developments/Updates
Table 150. Roche Competitive Strengths & Weaknesses
Table 151. Novartis Basic Information, Manufacturing Base and Competitors
Table 152. Novartis Major Business
Table 153. Novartis Immune Drugs Product and Services
Table 154. Novartis Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Novartis Recent Developments/Updates
Table 156. Novartis Competitive Strengths & Weaknesses
Table 157. Johnson & Johnson (J&J) Basic Information, Manufacturing Base and Competitors
Table 158. Johnson & Johnson (J&J) Major Business
Table 159. Johnson & Johnson (J&J) Immune Drugs Product and Services
Table 160. Johnson & Johnson (J&J) Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Johnson & Johnson (J&J) Recent Developments/Updates
Table 162. Johnson & Johnson (J&J) Competitive Strengths & Weaknesses
Table 163. Amgen Basic Information, Manufacturing Base and Competitors
Table 164. Amgen Major Business
Table 165. Amgen Immune Drugs Product and Services
Table 166. Amgen Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Amgen Recent Developments/Updates
Table 168. Abbvi Basic Information, Manufacturing Base and Competitors
Table 169. Abbvi Major Business
Table 170. Abbvi Immune Drugs Product and Services
Table 171. Abbvi Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 172. Global Key Players of Immune Drugs Upstream (Raw Materials)
Table 173. Immune Drugs Typical Customers
Table 174. Immune Drugs Typical Distributors
Table 1. World Immune Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Immune Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Immune Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Immune Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Immune Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Immune Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Immune Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Immune Drugs Production Market Share by Region (2018-2023)
Table 9. World Immune Drugs Production Market Share by Region (2024-2029)
Table 10. World Immune Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Immune Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Immune Drugs Major Market Trends
Table 13. World Immune Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Immune Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Immune Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Immune Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Immune Drugs Producers in 2022
Table 18. World Immune Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Immune Drugs Producers in 2022
Table 20. World Immune Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Immune Drugs Company Evaluation Quadrant
Table 22. World Immune Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Immune Drugs Production Site of Key Manufacturer
Table 24. Immune Drugs Market: Company Product Type Footprint
Table 25. Immune Drugs Market: Company Product Application Footprint
Table 26. Immune Drugs Competitive Factors
Table 27. Immune Drugs New Entrant and Capacity Expansion Plans
Table 28. Immune Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Immune Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Immune Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Immune Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Immune Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Immune Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Immune Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Immune Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Immune Drugs Production Market Share (2018-2023)
Table 37. China Based Immune Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Immune Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Immune Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Immune Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Immune Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Immune Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Immune Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Immune Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Immune Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Immune Drugs Production Market Share (2018-2023)
Table 47. World Immune Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Immune Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Immune Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Immune Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Immune Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Immune Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Immune Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Immune Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Immune Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Immune Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Immune Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Immune Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Immune Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Immune Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Antares Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Antares Pharma, Inc. Major Business
Table 63. Antares Pharma, Inc. Immune Drugs Product and Services
Table 64. Antares Pharma, Inc. Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Antares Pharma, Inc. Recent Developments/Updates
Table 66. Antares Pharma, Inc. Competitive Strengths & Weaknesses
Table 67. UCB Basic Information, Manufacturing Base and Competitors
Table 68. UCB Major Business
Table 69. UCB Immune Drugs Product and Services
Table 70. UCB Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. UCB Recent Developments/Updates
Table 72. UCB Competitive Strengths & Weaknesses
Table 73. Incyte Basic Information, Manufacturing Base and Competitors
Table 74. Incyte Major Business
Table 75. Incyte Immune Drugs Product and Services
Table 76. Incyte Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Incyte Recent Developments/Updates
Table 78. Incyte Competitive Strengths & Weaknesses
Table 79. GSK Basic Information, Manufacturing Base and Competitors
Table 80. GSK Major Business
Table 81. GSK Immune Drugs Product and Services
Table 82. GSK Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. GSK Recent Developments/Updates
Table 84. GSK Competitive Strengths & Weaknesses
Table 85. Takeda Basic Information, Manufacturing Base and Competitors
Table 86. Takeda Major Business
Table 87. Takeda Immune Drugs Product and Services
Table 88. Takeda Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Takeda Recent Developments/Updates
Table 90. Takeda Competitive Strengths & Weaknesses
Table 91. 3S Bio Basic Information, Manufacturing Base and Competitors
Table 92. 3S Bio Major Business
Table 93. 3S Bio Immune Drugs Product and Services
Table 94. 3S Bio Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. 3S Bio Recent Developments/Updates
Table 96. 3S Bio Competitive Strengths & Weaknesses
Table 97. Horizo??n Therapeutics Basic Information, Manufacturing Base and Competitors
Table 98. Horizo??n Therapeutics Major Business
Table 99. Horizo??n Therapeutics Immune Drugs Product and Services
Table 100. Horizo??n Therapeutics Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Horizo??n Therapeutics Recent Developments/Updates
Table 102. Horizo??n Therapeutics Competitive Strengths & Weaknesses
Table 103. Bristol-Myers Squibb (BMS Basic Information, Manufacturing Base and Competitors
Table 104. Bristol-Myers Squibb (BMS Major Business
Table 105. Bristol-Myers Squibb (BMS Immune Drugs Product and Services
Table 106. Bristol-Myers Squibb (BMS Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Bristol-Myers Squibb (BMS Recent Developments/Updates
Table 108. Bristol-Myers Squibb (BMS Competitive Strengths & Weaknesses
Table 109. Astellas Basic Information, Manufacturing Base and Competitors
Table 110. Astellas Major Business
Table 111. Astellas Immune Drugs Product and Services
Table 112. Astellas Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Astellas Recent Developments/Updates
Table 114. Astellas Competitive Strengths & Weaknesses
Table 115. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 116. Eli Lilly Major Business
Table 117. Eli Lilly Immune Drugs Product and Services
Table 118. Eli Lilly Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Eli Lilly Recent Developments/Updates
Table 120. Eli Lilly Competitive Strengths & Weaknesses
Table 121. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 122. Mitsubishi Tanabe Pharma Major Business
Table 123. Mitsubishi Tanabe Pharma Immune Drugs Product and Services
Table 124. Mitsubishi Tanabe Pharma Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 126. Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
Table 127. Biogen Basic Information, Manufacturing Base and Competitors
Table 128. Biogen Major Business
Table 129. Biogen Immune Drugs Product and Services
Table 130. Biogen Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Biogen Recent Developments/Updates
Table 132. Biogen Competitive Strengths & Weaknesses
Table 133. Pfizer Basic Information, Manufacturing Base and Competitors
Table 134. Pfizer Major Business
Table 135. Pfizer Immune Drugs Product and Services
Table 136. Pfizer Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Pfizer Recent Developments/Updates
Table 138. Pfizer Competitive Strengths & Weaknesses
Table 139. Sanofi Basic Information, Manufacturing Base and Competitors
Table 140. Sanofi Major Business
Table 141. Sanofi Immune Drugs Product and Services
Table 142. Sanofi Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Sanofi Recent Developments/Updates
Table 144. Sanofi Competitive Strengths & Weaknesses
Table 145. Roche Basic Information, Manufacturing Base and Competitors
Table 146. Roche Major Business
Table 147. Roche Immune Drugs Product and Services
Table 148. Roche Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Roche Recent Developments/Updates
Table 150. Roche Competitive Strengths & Weaknesses
Table 151. Novartis Basic Information, Manufacturing Base and Competitors
Table 152. Novartis Major Business
Table 153. Novartis Immune Drugs Product and Services
Table 154. Novartis Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Novartis Recent Developments/Updates
Table 156. Novartis Competitive Strengths & Weaknesses
Table 157. Johnson & Johnson (J&J) Basic Information, Manufacturing Base and Competitors
Table 158. Johnson & Johnson (J&J) Major Business
Table 159. Johnson & Johnson (J&J) Immune Drugs Product and Services
Table 160. Johnson & Johnson (J&J) Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Johnson & Johnson (J&J) Recent Developments/Updates
Table 162. Johnson & Johnson (J&J) Competitive Strengths & Weaknesses
Table 163. Amgen Basic Information, Manufacturing Base and Competitors
Table 164. Amgen Major Business
Table 165. Amgen Immune Drugs Product and Services
Table 166. Amgen Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Amgen Recent Developments/Updates
Table 168. Abbvi Basic Information, Manufacturing Base and Competitors
Table 169. Abbvi Major Business
Table 170. Abbvi Immune Drugs Product and Services
Table 171. Abbvi Immune Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 172. Global Key Players of Immune Drugs Upstream (Raw Materials)
Table 173. Immune Drugs Typical Customers
Table 174. Immune Drugs Typical Distributors
LIST OF FIGURES
Figure 1. Immune Drugs Picture
Figure 2. World Immune Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Immune Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Immune Drugs Production (2018-2029) & (K Units)
Figure 5. World Immune Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Immune Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Immune Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Immune Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Immune Drugs Production (2018-2029) & (K Units)
Figure 10. China Immune Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Immune Drugs Production (2018-2029) & (K Units)
Figure 12. Immune Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Immune Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Immune Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Immune Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Immune Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Immune Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Immune Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Immune Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Immune Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Immune Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Immune Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Immune Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Immune Drugs Markets in 2022
Figure 26. United States VS China: Immune Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Immune Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Immune Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Immune Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Immune Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Immune Drugs Production Market Share 2022
Figure 32. World Immune Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Immune Drugs Production Value Market Share by Type in 2022
Figure 34. Immune Boosting Drugs
Figure 35. Immunosuppressant Drugs
Figure 36. World Immune Drugs Production Market Share by Type (2018-2029)
Figure 37. World Immune Drugs Production Value Market Share by Type (2018-2029)
Figure 38. World Immune Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Immune Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Immune Drugs Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Surgery Center
Figure 44. Others
Figure 45. World Immune Drugs Production Market Share by Application (2018-2029)
Figure 46. World Immune Drugs Production Value Market Share by Application (2018-2029)
Figure 47. World Immune Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Immune Drugs Industry Chain
Figure 49. Immune Drugs Procurement Model
Figure 50. Immune Drugs Sales Model
Figure 51. Immune Drugs Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Immune Drugs Picture
Figure 2. World Immune Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Immune Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Immune Drugs Production (2018-2029) & (K Units)
Figure 5. World Immune Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Immune Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Immune Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Immune Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Immune Drugs Production (2018-2029) & (K Units)
Figure 10. China Immune Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Immune Drugs Production (2018-2029) & (K Units)
Figure 12. Immune Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Immune Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Immune Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Immune Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Immune Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Immune Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Immune Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Immune Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Immune Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Immune Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Immune Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Immune Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Immune Drugs Markets in 2022
Figure 26. United States VS China: Immune Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Immune Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Immune Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Immune Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Immune Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Immune Drugs Production Market Share 2022
Figure 32. World Immune Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Immune Drugs Production Value Market Share by Type in 2022
Figure 34. Immune Boosting Drugs
Figure 35. Immunosuppressant Drugs
Figure 36. World Immune Drugs Production Market Share by Type (2018-2029)
Figure 37. World Immune Drugs Production Value Market Share by Type (2018-2029)
Figure 38. World Immune Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Immune Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Immune Drugs Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Surgery Center
Figure 44. Others
Figure 45. World Immune Drugs Production Market Share by Application (2018-2029)
Figure 46. World Immune Drugs Production Value Market Share by Application (2018-2029)
Figure 47. World Immune Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Immune Drugs Industry Chain
Figure 49. Immune Drugs Procurement Model
Figure 50. Immune Drugs Sales Model
Figure 51. Immune Drugs Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
